Solitary Contralateral Adrenal Metastasis of Renal Cell Carcinoma: 68Ga-DOTATATE PET/CT Findings. (16th January 2022)

• Record Type: Journal Article
• Authors: Filizoglu, Nuh; Ozguven, Salih
• Is Part Of: Clinical nuclear medicine. Volume 47:Number 1(2022)
• Page Start: e41
• Page End: e42
• Publication Date: 2022-01-16
• Subjects: 68Ga-DOTATATE PET/CT -- renal cell carcinoma -- adrenal metastasis; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000003775
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract: 68 Ga-DOTATATE PET/CT is an imaging technique used in the diagnosis of neuroendocrine tumors. Since renal cell carcinoma (RCC) expresses the somatostatin receptors, 68 Ga-DOTATATE PET/CT could be used in the surveillance of RCC. However, limited cases showing 68 Ga-DOTATATE uptake in the metastases of RCC have been reported before. Herein, we report a case of a 55-year-old woman with a history of left nephrectomy for clear cell renal cell carcinoma 2 years before, and referred to 68 Ga-DOTATATE PET/CT for the evaluation of adrenal mass. 68 Ga-DOTATATE PET/CT showed intense 68 Ga-DOTATATE uptake on the adrenal mass. Histopathology of the adrenal mass confirmed the diagnosis of clear cell renal cell carcinoma metastasis.